The Board Members at POINT Biopharma provide strategic oversight and governance, guiding the company’s mission to develop and commercialize radioligand therapies for cancer treatment. They ensure good corporate practices, make high-level decisions, and support executive leadership in achieving clinical and commercial objectives.
View all